Annual Net Income
-$29.07 M
+$1.99 M+6.41%
31 December 2023
Summary:
Enlivex Therapeutics annual net profit is currently -$29.07 million, with the most recent change of +$1.99 million (+6.41%) on 31 December 2023. During the last 3 years, it has fallen by -$17.24 million (-145.84%). ENLV annual net income is now -12593.45% below its all-time high of -$229.00 thousand, reached on 31 December 2012.ENLV Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$3.10 M
+$1.04 M+25.22%
30 June 2024
Summary:
Enlivex Therapeutics quarterly net profit is currently -$3.10 million, with the most recent change of +$1.04 million (+25.22%) on 30 June 2024. Over the past year, it has increased by +$2.87 million (+48.08%). ENLV quarterly net income is now -207.76% below its all-time high of $2.87 million, reached on 31 December 2017.ENLV Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$22.29 M
+$3.70 M+14.22%
30 June 2024
Summary:
Enlivex Therapeutics TTM net profit is currently -$22.29 million, with the most recent change of +$3.70 million (+14.22%) on 30 June 2024. Over the past year, it has increased by +$4.87 million (+17.92%). ENLV TTM net income is now -9162.60% below its all-time high of $246.00 thousand, reached on 30 June 2018.ENLV TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.4% | +48.1% | +17.9% |
| 3 y3 years | -145.8% | +9.6% | -43.0% |
| 5 y5 years | -585.2% | -29.5% | -175.2% |
ENLV Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -145.8% | +6.4% | at high | +68.8% | -54.1% | +28.2% |
| 5 y | 5 years | -585.2% | +6.4% | -289.9% | +68.8% | -196.7% | +28.2% |
| alltime | all time | <-9999.0% | +6.4% | -207.8% | +68.8% | -9162.6% | +28.2% |
Enlivex Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$3.10 M(-25.2%) | -$22.29 M(-14.2%) |
| Mar 2024 | - | -$4.14 M(-54.5%) | -$25.99 M(-10.6%) |
| Dec 2023 | -$29.07 M(-6.4%) | -$9.10 M(+52.5%) | -$29.07 M(+7.0%) |
| Sept 2023 | - | -$5.96 M(-12.2%) | -$27.16 M(+0.9%) |
| June 2023 | - | -$6.79 M(-5.9%) | -$26.93 M(-10.4%) |
| Mar 2023 | - | -$7.22 M(+0.4%) | -$30.05 M(-3.2%) |
| Dec 2022 | -$31.06 M(+114.7%) | -$7.19 M(+25.4%) | -$31.06 M(+8.6%) |
| Sept 2022 | - | -$5.73 M(-42.2%) | -$28.61 M(+8.8%) |
| June 2022 | - | -$9.91 M(+20.5%) | -$26.30 M(+34.9%) |
| Mar 2022 | - | -$8.22 M(+73.7%) | -$19.49 M(+34.7%) |
| Dec 2021 | -$14.47 M(+22.4%) | -$4.74 M(+38.3%) | -$14.47 M(-7.2%) |
| Sept 2021 | - | -$3.42 M(+10.2%) | -$15.60 M(+9.1%) |
| June 2021 | - | -$3.11 M(-2.9%) | -$14.30 M(+0.5%) |
| Mar 2021 | - | -$3.20 M(-45.4%) | -$14.23 M(+20.3%) |
| Dec 2020 | -$11.82 M(+26.0%) | -$5.86 M(+176.0%) | -$11.82 M(+34.0%) |
| Sept 2020 | - | -$2.13 M(-30.1%) | -$8.83 M(-2.9%) |
| June 2020 | - | -$3.04 M(+283.0%) | -$9.09 M(+21.0%) |
| Mar 2020 | - | -$794.00 K(-72.3%) | -$7.51 M(-19.9%) |
| Dec 2019 | -$9.38 M(+121.2%) | -$2.87 M(+19.9%) | -$9.38 M(+15.8%) |
| Sept 2019 | - | -$2.39 M(+63.7%) | -$8.10 M(+18.9%) |
| June 2019 | - | -$1.46 M(-45.2%) | -$6.81 M(+15.8%) |
| Mar 2019 | - | -$2.67 M(+68.1%) | -$5.88 M(+38.7%) |
| Dec 2018 | -$4.24 M(+69.5%) | -$1.58 M(+43.8%) | -$4.24 M(-2073.5%) |
| Sept 2018 | - | -$1.10 M(+107.5%) | $215.00 K(-12.6%) |
| June 2018 | - | -$531.00 K(-48.2%) | $246.00 K(-128.7%) |
| Mar 2018 | - | -$1.02 M(-135.7%) | -$856.00 K(-65.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$2.50 M(-84.4%) | $2.87 M(-368.3%) | -$2.50 M(-70.4%) |
| Sept 2017 | - | -$1.07 M(-34.4%) | -$8.45 M(-29.9%) |
| June 2017 | - | -$1.63 M(-38.9%) | -$12.05 M(-14.6%) |
| Mar 2017 | - | -$2.67 M(-13.0%) | -$14.10 M(-12.0%) |
| Dec 2016 | -$16.02 M(+4.3%) | -$3.07 M(-34.2%) | -$16.02 M(-9.9%) |
| Sept 2016 | - | -$4.67 M(+26.7%) | -$17.78 M(+6.7%) |
| June 2016 | - | -$3.69 M(-19.8%) | -$16.66 M(-0.0%) |
| Mar 2016 | - | -$4.59 M(-4.9%) | -$16.66 M(+8.4%) |
| Dec 2015 | -$15.37 M(+118.8%) | -$4.83 M(+36.0%) | -$15.37 M(+12.3%) |
| Sept 2015 | - | -$3.55 M(-3.7%) | -$13.69 M(+11.8%) |
| June 2015 | - | -$3.69 M(+11.7%) | -$12.25 M(+26.6%) |
| Mar 2015 | - | -$3.30 M(+4.7%) | -$9.68 M(+37.8%) |
| Dec 2014 | -$7.02 M(+513.3%) | -$3.15 M(+49.3%) | -$7.02 M(+51.1%) |
| Sept 2014 | - | -$2.11 M(+89.5%) | -$4.65 M(+70.2%) |
| June 2014 | - | -$1.11 M(+72.7%) | -$2.73 M(+55.9%) |
| Mar 2014 | - | -$645.00 K(-17.0%) | -$1.75 M(+58.3%) |
| Dec 2013 | -$1.15 M(+400.0%) | -$777.00 K(+298.5%) | -$1.11 M(+235.5%) |
| Sept 2013 | - | -$195.00 K(+44.4%) | -$330.00 K(+144.4%) |
| June 2013 | - | -$135.00 K | -$135.00 K |
| Dec 2012 | -$229.00 K(-73.0%) | - | - |
| Dec 2002 | -$849.00 K(-47.5%) | - | - |
| Dec 2001 | -$1.62 M(+26.0%) | - | - |
| Dec 2000 | -$1.28 M(+86.8%) | - | - |
| Dec 1999 | -$687.10 K(-59.5%) | - | - |
| Dec 1998 | -$1.70 M(-24.9%) | - | - |
| Dec 1997 | -$2.26 M | - | - |
FAQ
- What is Enlivex Therapeutics annual net profit?
- What is the all time high annual net income for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual net income year-on-year change?
- What is Enlivex Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly net income year-on-year change?
- What is Enlivex Therapeutics TTM net profit?
- What is the all time high TTM net income for Enlivex Therapeutics?
- What is Enlivex Therapeutics TTM net income year-on-year change?
What is Enlivex Therapeutics annual net profit?
The current annual net income of ENLV is -$29.07 M
What is the all time high annual net income for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual net profit is -$229.00 K
What is Enlivex Therapeutics annual net income year-on-year change?
Over the past year, ENLV annual net profit has changed by +$1.99 M (+6.41%)
What is Enlivex Therapeutics quarterly net profit?
The current quarterly net income of ENLV is -$3.10 M
What is the all time high quarterly net income for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly net profit is $2.87 M
What is Enlivex Therapeutics quarterly net income year-on-year change?
Over the past year, ENLV quarterly net profit has changed by +$2.87 M (+48.08%)
What is Enlivex Therapeutics TTM net profit?
The current TTM net income of ENLV is -$22.29 M
What is the all time high TTM net income for Enlivex Therapeutics?
Enlivex Therapeutics all-time high TTM net profit is $246.00 K
What is Enlivex Therapeutics TTM net income year-on-year change?
Over the past year, ENLV TTM net profit has changed by +$4.87 M (+17.92%)